In March 2025, Raisio published its strategy for 2025–2027 based on three growth areas: Breakfast and snacking, Heart health, and New Business to Raisio. The company focuses on utilizing its strong balance sheet more efficiently to accelerate growth through targeted acquisitions and investments in research activities.
Cyborg Score Rationale
Raisio demonstrates solid fundamentals with revenue growth, improving profitability, and a clear strategic focus on high-margin healthy food categories. Recent divestments have streamlined operations, and the company maintains a strong balance sheet enabling future growth investments.
Top Insights
Recently divested plant protein business (March 2025) to focus on core competencies
Strong profitability improvements driven by consumer brand sales growth in Q3 2025
Benecol plant stanol portfolio represents key differentiated product with strong IP protection
International presence in 40+ markets with concentrated European footprint in UK, Ireland, Poland
Named Competitors
Plant-based and Functional Foods — Global snacking and functional food products
Healthy Breakfast and Oat Products — Oat-based breakfast and functional foods
Heart Health and Spreads — Functional spreads and plant-based products
Recent Developments
(March 2025) Published new 2025-2027 strategy focusing on Breakfast/Snacking, Heart Health, and New Business segments
(March 2025) Sold plant protein business to streamline portfolio
(Q3 2025) Reported net sales of EUR 59.1M with 5.4% growth and improved EBITDA margins
(December 2024) Announced organizational restructuring into two category-focused areas
Open the full interactive Raisio plc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.